Tower Research Capital LLC (Trc) Xilio Therapeutics, Inc. Transaction History
Tower Research Capital LLC (Trc)
- $3.53 Billion
- Q2 2025
A detailed history of Tower Research Capital LLC (Trc) transactions in Xilio Therapeutics, Inc. stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 15,412 shares of XLO stock, worth $10,788. This represents 0.0% of its overall portfolio holdings.
Number of Shares
15,412Holding current value
$10,788% of portfolio
0.0%Shares
14 transactions
Others Institutions Holding XLO
# of Institutions
35Shares Held
12.8MCall Options Held
0Put Options Held
0-
Bain Capital Life Sciences Investors, LLC Boston, MA4.57MShares$3.2 Million0.93% of portfolio
-
Morgan Stanley New York, NY1.44MShares$1.01 Million0.0% of portfolio
-
River Vest Venture Management LLC St. Louis, MO1.44MShares$1.01 Million16.6% of portfolio
-
Ghisallo Capital Management LLC Greenwich, CT1.33MShares$933,0990.05% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.15MShares$805,7160.0% of portfolio
About Xilio Therapeutics, Inc.
- Ticker XLO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 27,471,600
- Market Cap $19.2M
- Description
- Xilio Therapeutics, Inc., a clinical-stage biotechnology company, develops immunotherapies to improve the immune system of cancer patients. Its checkpoint inhibitor program includes XTX101, a clinical-stage, tumor-selective anti-CTLA-4 mAb that is in Phase 1/2 clinical trials in patients with solid tumors. The company also develops cytokine prog...